200 related articles for article (PubMed ID: 22393583)
1. Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations.
Sahib MN; Abdulameer SA; Darwis Y; Peh KK; Tan YT
Drug Des Devel Ther; 2012; 6():29-42. PubMed ID: 22393583
[TBL] [Abstract][Full Text] [Related]
2. Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.
Sahib MN; Darwis Y; Peh KK; Abdulameer SA; Tan YT
Int J Nanomedicine; 2011; 6():2351-66. PubMed ID: 22072872
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids.
Craparo EF; Teresi G; Bondi' ML; Licciardi M; Cavallaro G
Int J Pharm; 2011 Mar; 406(1-2):135-44. PubMed ID: 21185363
[TBL] [Abstract][Full Text] [Related]
4. Characterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionate.
Gaber NN; Darwis Y; Peh KK; Tan YT
J Nanosci Nanotechnol; 2006; 6(9-10):3095-101. PubMed ID: 17048523
[TBL] [Abstract][Full Text] [Related]
5. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
6. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
[TBL] [Abstract][Full Text] [Related]
7. PHEA-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs.
Licciardi M; Di Stefano M; Craparo EF; Amato G; Fontana G; Cavallaro G; Giammona G
Int J Pharm; 2012 Aug; 433(1-2):16-24. PubMed ID: 22575755
[TBL] [Abstract][Full Text] [Related]
8. Beclomethasone-loaded lipidic nanocarriers for pulmonary drug delivery: preparation, characterization and in vitro drug release.
Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
J Nanosci Nanotechnol; 2011 Mar; 11(3):1841-51. PubMed ID: 21449319
[TBL] [Abstract][Full Text] [Related]
9. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
Zeng XM; Pandhal KH; Martin GP
Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
[TBL] [Abstract][Full Text] [Related]
10. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.
Marianecci C; Paolino D; Celia C; Fresta M; Carafa M; Alhaique F
J Control Release; 2010 Oct; 147(1):127-35. PubMed ID: 20603167
[TBL] [Abstract][Full Text] [Related]
11. Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases.
De Leo V; Ruscigno S; Trapani A; Di Gioia S; Milano F; Mandracchia D; Comparelli R; Castellani S; Agostiano A; Trapani G; Catucci L; Conese M
Int J Pharm; 2018 Jul; 545(1-2):378-388. PubMed ID: 29678545
[TBL] [Abstract][Full Text] [Related]
12. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
13. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ; Stampone P; O'Connor BJ
Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
[TBL] [Abstract][Full Text] [Related]
14. Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded glucocorticoid after aerosolization in mice.
Craparo EF; Di Gioia S; Trapani A; Cellamare S; Belgiovine G; Mandracchia D; Giammona G; Cavallaro G; Conese M
Int J Pharm; 2016 Aug; 510(1):263-70. PubMed ID: 27326484
[TBL] [Abstract][Full Text] [Related]
15. Polymeric drug delivery micelle-like nanocarriers for pulmonary administration of beclomethasone dipropionate.
Triolo D; Craparo EF; Porsio B; Fiorica C; Giammona G; Cavallaro G
Colloids Surf B Biointerfaces; 2017 Mar; 151():206-214. PubMed ID: 28013164
[TBL] [Abstract][Full Text] [Related]
16. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
Gross G; Thompson PJ; Chervinsky P; Vanden Burgt J
Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
[TBL] [Abstract][Full Text] [Related]
17. Limitations of high dose carrier based formulations.
Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
Int J Pharm; 2018 Jun; 544(1):141-152. PubMed ID: 29649519
[TBL] [Abstract][Full Text] [Related]
18. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
19. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
[TBL] [Abstract][Full Text] [Related]
20. Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles.
Lim SB; Rubinstein I; Onyüksel H
Int J Pharm; 2008 May; 356(1-2):345-50. PubMed ID: 18289811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
